Breaking News Instant updates and real-time market news.

PHM

PulteGroup

$24.43

0.065 (0.27%)

, BZH

Beazer Homes

$13.66

0.11 (0.81%)

10:57
07/17/17
07/17
10:57
07/17/17
10:57

Homebuilder shares may be ahead of themselves, Reuters says

Shares of homebuilders, which as a sector have seen their "biggest rally in five years" may be due for a pullback, said Reuters, citing certain investors. "Housing optimists are pinning their bets on strong U.S. job creation, low interest rates, tight housing supply, robust earnings estimates and a lack of recessionary red flags," said Reuters in a report out late last week. According to the report, Erin Browne, global macro portfolio manager at UBS O'Connor in New York, said, "The sentiment has been quite positive for housing but where they are today, I'm not a buyer of housing stocks. The stocks have run up faster than the data supports and there are better pockets of value in the market." Publicly traded companies in the space include Beazer Homes (BZH), D.R. Horton (DHI), Hovnanian (HOV), KB Home (KBH), Lennar (LEN), M.D.C. Holdings (MDC), Merged into CAA (RYL), PulteGroup (PHM) and Toll Brothers (TOL). Reference Link

PHM

PulteGroup

$24.43

0.065 (0.27%)

BZH

Beazer Homes

$13.66

0.11 (0.81%)

RYL

Merged into CAA

HOV

Hovnanian

$2.56

0.11 (4.49%)

DHI

D.R. Horton

$36.86

0.155 (0.42%)

LEN

Lennar

$53.94

-0.09 (-0.17%)

KBH

KB Home

$23.78

0.12 (0.51%)

MDC

M.D.C. Holdings

$36.28

0.19 (0.53%)

TOL

Toll Brothers

$40.04

-0.13 (-0.32%)

  • 25

    Jul

  • 26

    Jul

  • 01

    Aug

  • 01

    Aug

PHM PulteGroup
$24.43

0.065 (0.27%)

06/27/17
BOFA
06/27/17
NO CHANGE
BOFA
US housing cycle may be inflecting higher, says BofA/Merrill
BofA/Merrill analyst John Lovallo raised single-family house starts and new home sales forecasts for 2018 and 2019 to reflect a continuation in accelerating demand over the past six months. He now expects 2018 single family starts and new homes sales of up 9% year-over-year versus 6% previously, and 2019 growth of up 8% growth year-over-year, versus 5% previously. The analyst believes demand is being supported by the return of first time home buyers, low mortgage rates, and stronger home equity positions. Lovallo raised earnings estimates across the group and reiterated D.R. Horton (DHI) and PulteGroup (PHM) as top picks.
06/22/17
FBCO
06/22/17
INITIATION
Target $27
FBCO
Outperform
PulteGroup initiated with an Outperform at Credit Suisse
Credit Suisse analyst Susan Maklari initiated PulteGroup with an Outperform and a $27 price target saying it is among her top pics in housing. Maklari expects Pulte to benefit from its diverse product offerings geared towards baby boomers and millennials, a focus on construction efficiencies and controlling costs, and its balanced approach to capital allocation.
05/16/17
MZHO
05/16/17
INITIATION
Target $22
MZHO
Neutral
PulteGroup initiated with a Neutral at Mizuho
Mizuho analyst Haendel St. Juste initiated PulteGroup with a Neutral and a $22 price target.
03/07/17
LEHM
03/07/17
NO CHANGE
LEHM
Barclays sees additiona near-term upside for builders
Barclays analyst Michael Dahl says his firm's February survey indicates "strong" early spring demand for U.S. homebuilders. Upcoming catalysts for the group will likely be positive, Dahl tells investors in a research note. The analyst sees "modest" further near-term upside for builder stocks despite the recent rallies. His Overweight rated names are PulteGroup (PHM), Lennar (LEN) and TRI Pointe (TPH). Dahl also believes D.R. Horton (DHI) is well positioned to capture incremental demand. He raised his price target for the shares to $34 from $30 but keeps an Equal Weight rating due to valuation.
BZH Beazer Homes
$13.66

0.11 (0.81%)

06/15/17
WEDB
06/15/17
UPGRADE
WEDB
Outperform
Beazer Homes upgraded to Outperform from Neutral at Wedbush
06/15/17
WEDB
06/15/17
UPGRADE
WEDB
Outperform
Beazer Homes upgraded on loosening credit standards at Wedbush
As noted earlier, Wedbush upgraded Beazer Homes (BZH) to Outperform from Neutral. Analyst Jay McCanless upgraded the stock based on what he sees as "the loosening of credit standards at Fannie Mae (FNMA)." The analyst says that Beazer focuses on "entry level consumers who..benefit most from lower lending standards." Target remains $15.
06/15/17
06/15/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. La Quinta (LQ) upgraded to Overweight from Equal Weight at Morgan Stanley with the firm's analyst indicating a more bullish outlook for lodging demand given the stronger economy and raised La Quinta estimates, and notes shares have underperformed year-to-date. 2. Paccar (PCAR) upgraded to Buy from Neutral at Goldman Sachs with analyst Jerry Revinch saying he is positive on the company's prospects to further improve its industry-leading returns on capital. 3. Thomson Reuters (TRI) upgraded to Outperform from Neutral at Macquarie with analyst Giasone Salati saying he now believes the company is well positioned for what might be a once-in-a-decade boost in demand for services by MIFID II investment firms. 4. Beazer Homes (BZH) upgraded to Outperform from Neutral at Wedbush with analyst Jay McCanless citing what he sees as "the loosening of credit standards at Fannie Mae (FNMA)." 5. Enterprise Products (EPD) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Tom Abrams citing relative valuation and said the company should benefit from improving ethane markets over the next few years. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/22/17
FBCO
06/22/17
INITIATION
Target $13
FBCO
Neutral
Beazer Homes initiated with a Neutral at Credit Suisse
Credit Suisse analyst Susan Maklari initiated Beazer Homes with a Neutral and a $13 price target due to valuation and said she would wait for a better entry point.
RYL Merged into CAA

HOV Hovnanian
$2.56

0.11 (4.49%)

01/12/17
JMPS
01/12/17
DOWNGRADE
JMPS
Underperform
Hovnanian downgraded to Underperform from Market Perform at JMP Securities
01/12/17
JMPS
01/12/17
DOWNGRADE
JMPS
Underperform
Hovnanian downgraded on valuation, tough comps at JMP Securities
As noted earlier, JMP Securities downgraded Hovnanian to Underperform from Market Perform. As reasons for the downgrade, analyst Peter Martin cited valuation and "extremely difficult community count comps" in 1H17. Target $1.60.
DHI D.R. Horton
$36.86

0.155 (0.42%)

06/22/17
FBCO
06/22/17
INITIATION
Target $38
FBCO
Outperform
D.R. Horton initiated with an Outperform at Credit Suisse
Credit Suisse analyst Susan Maklari initiated D.R. Horton with an Outperform and a $38 price target saying it is among the best positioned builders under coverage. Maklari said D.R. Horton is well positioned to drive volume growth and control overhead costs, even as they expand. Its core competencies will drive accelerated earnings and and further share gains in entry level housing, combined with cost improvements and reduced SG&A will drive upside potential.
06/30/17
RAJA
06/30/17
UPGRADE
Target $39
RAJA
Outperform
D.R. Horton upgraded to Outperform from Market Perform at Raymond James
Raymond James upgraded D.R. Horton to Outperform and established a $39 price target saying it is uniquely positioned to capitalize on an unexpectedly tight and historically low existing home inventories, while new home demand remains broadly resilient despite rising prices. The analyst believes homebuilders with ample supply of quick delivery homes at affordable price points stand to benefit the most.
06/30/17
06/30/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Cabot Oil & Gas (COG) upgraded to Buy from Neutral at BofA/Merrill with analyst Doug Leggate saying Cabot 's gross Marcellus takeaway capacity will increase to 3.7 bcf/d from 2bcf/d by end of 2018 and positioned to increase free cash flow to $2B from $872M per year for 25 years. 2. Becton Dickinson (BDX) upgraded to Strong Buy from Outperform at Raymond James with analyst Lawrence Keusch saying he believes it should be a core holding based an an above average outlook for 5%-6% organic growth and mid-teens earnings increases with further potential upside. 3. Walgreens Boots Alliance (WBA) upgraded to Buy from Hold at Needham. 4. ManTech (MANT) upgraded to Buy from Hold at Loop Capital with analyst Joseph Vafi saying he sees "company-specific and secular catalysts" driving improving fundamentals and upward revisions to consensus estimates. 5. D.R. Horton (DHI) upgraded to Outperform from Market Perform at Raymond James with the firm saying it is uniquely positioned to capitalize on an unexpectedly tight and historically low existing home inventories, while new home demand remains broadly resilient despite rising prices. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
LEN Lennar
$53.94

-0.09 (-0.17%)

05/16/17
MZHO
05/16/17
INITIATION
Target $59
MZHO
Buy
Lennar initiated with a Buy at Mizuho
Mizuho analyst Haendel St. Juste initiated Lennar with a Buy and a $59 price target.
06/22/17
FBCO
06/22/17
INITIATION
Target $55
FBCO
Neutral
Lennar initiated with a Neutral at Credit Suisse
Credit Suisse analyst Susan Maklari initiated Lennar with a Neutral and a $55 price target due to valuation.
06/21/17
EVER
06/21/17
DOWNGRADE
Target $56
EVER
In Line
Lennar downgraded to In Line from Outperform at Evercore ISI
Evercore ISI analyst Stephen Kim downgraded Lennar to In Line citing valuation and increased its price target to $56 from $54.
KBH KB Home
$23.78

0.12 (0.51%)

05/16/17
MZHO
05/16/17
INITIATION
Target $20
MZHO
Neutral
KB Home initiated with a Neutral at Mizuho
Mizuho analyst Haendel St. Juste initiated KB Home with a Neutral and a $20 price target.
06/22/17
FBCO
06/22/17
INITIATION
Target $23
FBCO
Neutral
KB Home initiated with a Neutral at Credit Suisse
Credit Suisse analyst Susan Maklari initiated KB Home with a Neutral and a $23 price target given below-average profitability and elevated leverage.
06/15/17
WEDB
06/15/17
NO CHANGE
WEDB
KB Home should be owned ahead of earnings, says Wedbush
Wedbush analyst Jay McCanless expects KB Home (KBH) to benefit from what he sees as loser credit standards by Fannie Mae (FNMA). The analyst raised his price target on KB Home to $24 from $22 He recommends owning the stock ahead of the company's Q2 results as he expects its EPS to come in 1c above the consensus outlook. He keeps an Outperform rating on the name.
MDC M.D.C. Holdings
$36.28

0.19 (0.53%)

05/17/17
DBAB
05/17/17
NO CHANGE
DBAB
Firestone incident could hurt Colorado homebuilding, says Deutsche Bank
Deutsche Bank analyst Nishu Sood performed on analysis on the Century Communities (CCS) home that exploded in April due to a gas leak from a nearby oil and gas well flow line that hadn't been properly sealed. The incident at Firestone claimed two lives and set off a "vigorous debate about how to ensure the safety of existing and new development," Sood tells investors in a research note. He believes the incident could "significantly affect" homebuilding in Colorado and pegs Century Communities and M.D.C. Holdings (MDC) as being most exposed. Nearly 30% of M.D.C. and Century's revenues are driven by Colorado, the analyst tells investors in a research note. He adds that Meritage Homes (MTH) and LGI Homes (LGIH) also likely have roughly 10% revenue exposure to Colorado.
05/10/17
SBSH
05/10/17
DOWNGRADE
SBSH
Neutral
M.D.C. Holdings downgraded to Neutral from Buy at Citi
Citi analyst Will Randow downgraded M.D.C. Holdings to Neutral citing valuation following the company's "solid" Q1 results.
05/16/17
WELS
05/16/17
DOWNGRADE
Target $30
WELS
Underperform
M.D.C. Holdings downgraded to Underperform from Market Perform at Wells Fargo
Wells Fargo analyst Stephen East downgraded M.D.C. Holdings to Underperform citing the stock's 37% rise year-to-date, "poor" fundamentals and a lack of catalysts. Most of the company's metrics "sit at or near the bottom of our Homebuilder group and below historical averages," East tells investors in a research note. He has a $30 price target for the shares.
TOL Toll Brothers
$40.04

-0.13 (-0.32%)

05/24/17
BUCK
05/24/17
DOWNGRADE
Target $38
BUCK
Neutral
Toll Brothers downgraded to Neutral on valuation at Buckingham
Buckingham analyst Mark Weintraub downgraded Toll Brothers to Neutral from Buy citing recent share strength and raised his price target to $39 from $38.
05/24/17
05/24/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. AutoZone (AZO) downgraded to Equal Weight from Overweight at Stephens with analyst Ben Bienvenu citing the company's third quarter earnings report. 2. Ooma (OOMA) was downgraded to Market Perform from Outperform at William Blair, to Neutral from Outperform at Credit Suisse, to Underperform from Buy at BofA/Merrill, and to Market Perform from Outperform at William Blair. 3. Momo (MOMO) downgraded to Neutral from Overweight at JPMorgan with analyst Alex Yao citing the company's first quarter results. 4. Toll Brothers (TOL) downgraded to Neutral on valuation at Buckingham with analyst Mark Weintraub citing recent share strength and raised his price target to $39 from $38. 5. Accenture (ACN) downgraded to Hold from Buy at SunTrust with analyst Frank Atkins citing valuation and maintained a $130 price target. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/22/17
FBCO
06/22/17
INITIATION
Target $39
FBCO
Neutral
Toll Brothers initiated with a Neutral at Credit Suisse
Credit Suisse analyst Susan Maklari initiated Toll Brothers with a Neutral and a $39 price target saying she would wait for a better entry point to before buying shares.

TODAY'S FREE FLY STORIES

HK

Halcon Resources

$5.90

-0.1 (-1.67%)

07:33
10/17/17
10/17
07:33
10/17/17
07:33
Upgrade
Halcon Resources rating change  »

Halcon Resources upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Nov

  • 15

    May

  • 16

    May

MDXG

MiMedx

$13.51

0.31 (2.35%)

07:32
10/17/17
10/17
07:32
10/17/17
07:32
Hot Stocks
MiMedx notified by FDA to proceed with Phase 2B IND trial for osteoarthritis »

MiMedx has been notified…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 08

    Nov

  • 09

    Nov

  • 10

    Nov

  • 13

    Nov

  • 14

    Nov

IPXL

Impax

$19.95

-0.85 (-4.09%)

07:31
10/17/17
10/17
07:31
10/17/17
07:31
Hot Stocks
Breaking Hot Stocks news story on Impax »

Impax, Amneal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

JBL

Jabil Circuit

$28.61

0.37 (1.31%)

07:31
10/17/17
10/17
07:31
10/17/17
07:31
Recommendations
Jabil Circuit analyst commentary  »

Jabil Circuit strength in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVTCY

Evotec

$51.15

2.3099 (4.73%)

07:31
10/17/17
10/17
07:31
10/17/17
07:31
Conference/Events
Evotec management to meet with Deutsche Bank »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

GPRO

GoPro

$9.08

-0.48 (-5.02%)

, CREE

Cree

$29.28

-0.08 (-0.27%)

07:30
10/17/17
10/17
07:30
10/17/17
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

GPRO

GoPro

$9.08

-0.48 (-5.02%)

CREE

Cree

$29.28

-0.08 (-0.27%)

MT

ArcelorMittal

$28.99

-0.36 (-1.23%)

PXD

Pioneer Natural

$143.69

-0.23 (-0.16%)

BABY

Natus Medical

$39.35

-0.75 (-1.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 25

    Oct

  • 01

    Nov

  • 02

    Nov

CARB

Carbonite

$22.30

-0.5 (-2.19%)

07:30
10/17/17
10/17
07:30
10/17/17
07:30
Initiation
Carbonite initiated  »

Carbonite initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

NEWS

NewStar Financial

$12.13

0.23 (1.93%)

07:30
10/17/17
10/17
07:30
10/17/17
07:30
Hot Stocks
Breaking Hot Stocks news story on NewStar Financial »

NewStar Financial trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JRVR

James River Group

$41.95

-0.08 (-0.19%)

07:27
10/17/17
10/17
07:27
10/17/17
07:27
Initiation
James River Group initiated  »

James River Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

MDB

MongoDB

07:27
10/17/17
10/17
07:27
10/17/17
07:27
Syndicate
MongoDB IPO deal range increased to $20.00-$22.00 »

MongoDB 's 8M share…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

NFLX

Netflix

$202.68

3.19 (1.60%)

07:26
10/17/17
10/17
07:26
10/17/17
07:26
Recommendations
Netflix analyst commentary  »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

PSX

Phillips 66

$90.87

-3.56 (-3.77%)

07:26
10/17/17
10/17
07:26
10/17/17
07:26
Recommendations
Phillips 66 analyst commentary  »

Phillips 66 price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

VZ

Verizon

$48.09

0.23 (0.48%)

07:25
10/17/17
10/17
07:25
10/17/17
07:25
Periodicals
Verizon FiOS stops carrying Univision, WSJ reports »

Verizon FiOS has stopped…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 01

    Nov

VLO

Valero

$77.42

-0.66 (-0.85%)

07:25
10/17/17
10/17
07:25
10/17/17
07:25
Recommendations
Valero analyst commentary  »

Valero price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

SNDX

Syndax

$12.76

0.39 (3.15%)

07:25
10/17/17
10/17
07:25
10/17/17
07:25
Syndicate
Syndax raises $25M in a registered direct offering »

Syndax announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMDZ

Immune Design

$10.10

-0.85 (-7.76%)

07:25
10/17/17
10/17
07:25
10/17/17
07:25
Conference/Events
Immune Design to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 08

    Nov

CVS

CVS Health

$72.44

-0.16 (-0.22%)

07:25
10/17/17
10/17
07:25
10/17/17
07:25
Conference/Events
Economic Club of New York to hold a breakfast meeting »

Larry Merlo, President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 20

    Oct

  • 06

    Nov

  • 12

    Dec

CVS

CVS Health

$72.44

-0.16 (-0.22%)

07:25
10/17/17
10/17
07:25
10/17/17
07:25
Conference/Events
Economic Club of New York to hold a breakfast meeting »

Larry Merlo, President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 20

    Oct

  • 06

    Nov

  • 12

    Dec

IPXL

Impax

$19.95

-0.85 (-4.09%)

07:24
10/17/17
10/17
07:24
10/17/17
07:24
Hot Stocks
Breaking Hot Stocks news story on Impax »

Impax trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

ANDV

Andeavor

$103.82

-1.55 (-1.47%)

07:24
10/17/17
10/17
07:24
10/17/17
07:24
Recommendations
Andeavor analyst commentary  »

Andeavor price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCMD

Tactile Systems

$30.87

-1.05 (-3.29%)

07:23
10/17/17
10/17
07:23
10/17/17
07:23
Initiation
Tactile Systems initiated  »

Tactile Systems initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

AGN

Allergan

07:22
10/17/17
10/17
07:22
10/17/17
07:22
Recommendations
Allergan analyst commentary  »

Allergan court ruling on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 23

    Oct

  • 01

    Nov

  • 06

    Nov

GRPN

Groupon

$4.70

0.07 (1.51%)

07:22
10/17/17
10/17
07:22
10/17/17
07:22
Initiation
Groupon initiated  »

Groupon initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 16

    Nov

FANG

Diamondback Energy

$102.60

1.23 (1.21%)

07:21
10/17/17
10/17
07:21
10/17/17
07:21
Recommendations
Diamondback Energy analyst commentary  »

Diamondback Energy price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

UNFI

United Natural Foods

$40.57

0.09 (0.22%)

, AMZN

Amazon.com

$1,006.34

3.4 (0.34%)

07:21
10/17/17
10/17
07:21
10/17/17
07:21
Downgrade
United Natural Foods, Amazon.com rating change  »

United Natural Foods…

UNFI

United Natural Foods

$40.57

0.09 (0.22%)

AMZN

Amazon.com

$1,006.34

3.4 (0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 26

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.